Chronus Pharmaceuticals

No. 280: A TCJA counterattack, an interstate healthcare alliance and baby, it’s cold outside (but it could be colder)

Weekend forecast: Welcome to the blessed end of another busy work week, dear readers – and speaking of endings and beginnings, happy anniversary to the National Weather Service, launched on this date (by the U.S. Army, believe it or not) 148 years ago today. The NWS likely had a field day on its 64th anniversary – Feb. 9, 1934 – when New York City, amidst a legendary arctic blast that deep-froze much of the nation,…


NIH backs SBU-based biotech’s tuberculosis effort

By GREGORY ZELLER // A Setauket-based pharmaceuticals startup specializing in biomarker analysis has landed a chunky National Institutes of Health research award. Chronus Pharmaceuticals, founded and managed by researchers representing Stony Brook University and an assortment of other prestigious research institutions, announced this week that it has received a $299,172 Phase I Small Business Technology Transfer award from the NIH’s National Institute of Allergy and Infectious Diseases. The award, received in partnership with SBU’s Department…